PRESS RELEASE published on 03/04/2026 at 07:03, 7 months 15 days ago EQS-Adhoc: adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board adidas AG extends Bjørn Gulden’s contract as Chief Executive Officer and initiates transition at the helm of the Supervisory Board. Key personnel decisions announced Supervisory Board Chief Executive Officer Personnel Decisions Adidas AG Bjørn Gulden
REGULATED PRESS RELEASE published on 03/04/2026 at 07:02, 7 months 15 days ago TERACT - Availibility of the Half-year Financial Report As of 31 December 2025 TERACT announces availability of its half-year financial report as of 31 December 2025, compliant with regulations, filed with AMF and accessible on company and AMF websites Financial Statements TERACT AMF Regulations Half-year Financial Report
REGULATED PRESS RELEASE published on 03/04/2026 at 07:02, 7 months 15 days ago TERACT - H1 2025-2026 results TERACT's H1 2025-2026 results impacted by store disposals amid sluggish market conditions. InVivo Group proposes public buy-out and squeeze-out of TERACT shares to support new roadmap TERACT Results Store Disposals InVivo Group H1 2025-2026
PRESS RELEASE published on 03/04/2026 at 07:00, 7 months 15 days ago Fourth quarter 2025 Results - EUR 208 million net income in Q4 2025, contributing to a strong full year net income of EUR 851 million - Proposed regular dividend of EUR 1.9 per share SCOR SE reports EUR 208 million net income in Q4 2025, contributing to a strong full year net income of EUR 851 million. Proposed regular dividend of EUR 1.9 per share approved by the Board Financial Results Net Income Dividend Scor SE Q4 2025
PRESS RELEASE published on 03/04/2026 at 07:00, 7 months 15 days ago BioVersys Announces Publication of BV100 Phase 1 Clinical Data in Journal of Antimicrobial Agents and Chemotherapy BioVersys announces publication of BV100 Phase 1 clinical data in Journal of Antimicrobial Agents and Chemotherapy Clinical Data Phase 1 BV100 BioVersys Antibacterial
PRESS RELEASE published on 03/04/2026 at 06:45, 7 months 15 days ago Anja Hendel, Max Müller and Peter Schmid von Linstow to be nominated to the Supervisory Board of Redcare Pharmacy. Anja Hendel, Max Müller and Peter Schmid von Linstow nominated to Redcare Pharmacy's Supervisory Board, enhancing expertise & strategic oversight. Björn Söder, Jérôme Cochet, Jaska de Bakker to step down Governance Supervisory Board Expertise Redcare Pharmacy Nominees
PRESS RELEASE published on 03/04/2026 at 06:44, 7 months 15 days ago PALFINGER AG – THIRD-BEST FISCAL YEAR IN THE COMPANY'S HISTORY AND FOCUS ON PROFITABLE GROWTH PALFINGER AG reports third-best fiscal year, with EUR 2.34 billion revenue, EUR 174.3 million EBIT, and focus on profitable growth. Strong balance sheet and global expansion strategies Global Expansion Financial Performance Profitable Growth Fiscal Year PALFINGER AG
PRESS RELEASE published on 03/04/2026 at 06:30, 7 months 15 days ago Redcare Pharmacy: Strong growth in 2025 surpassing EUR 1bn in Rx revenue; adj. EBITDA up 72% yoy. Redcare Pharmacy reports strong growth in 2025, surpassing EUR 1bn in Rx revenue with adj. EBITDA up 72% yoy. Active customers grow to 13.9M. Guidance for 2026: 13%-15% revenue growth, adj. EBITDA margin 2.5% Adjusted EBITDA Redcare Pharmacy 2025 Growth Rx Revenue 2026 Guidance
PRESS RELEASE published on 03/04/2026 at 06:15, 7 months 15 days ago 2025 financial year – Increased results and positive growth prospects for Implenia Implenia AG reports improved operating profit and positive growth prospects for 2025 financial year with increased EBIT forecast for 2026 and proposed dividend hike. Details on order book, cash flow, personnel changes, and sustainability goals Financial Results Sustainability Goals Dividend Increase Implenia AG Growth Prospects
PRESS RELEASE published on 03/04/2026 at 04:50, 7 months 15 days ago BYDFi Named Best All-in-One Crypto Trading Platform at Crypto Expo Europe, Extending Awards Momentum BYDFi named Best All-in-One Crypto Trading Platform at Crypto Expo Europe 2026, extending awards momentum. Recognized for end-to-end trading experience combining market access, product completeness, and usability Awards Trading Platform Crypto Exchange BYDFi Crypto Expo Europe
Published on 10/19/2026 at 09:05, 1 hour 38 minutes ago BioNxt Completes GMP Manufacturing and Submits Clinical Trial Application for Sublingual Cladribine Drug Candidate
Published on 10/17/2026 at 03:20, 2 days 7 hours ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 2 days 7 hours ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 2 days 11 hours ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 2 days 11 hours ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/19/2026 at 10:15, 28 minutes ago Hong Kong and Chinese Mainland Enterprises Go Global Together: Bringing Enormous Opportunities to Global Talent in the UK
Published on 10/19/2026 at 10:05, 38 minutes ago N&S SCHWEIßTECHNIK DELIVERS FLEXIBLE & AUTOMATED PRODUCTION WITH PANASONIC
Published on 10/19/2026 at 10:00, 43 minutes ago CEOTRONICS receives order for ground crew communication systems worth approx. €2 million
Published on 10/19/2026 at 09:49, 53 minutes ago EQS-Adhoc: NEXTDC Limited - trading halt of ordinary shares on the Australian Securities Exchange
Published on 10/19/2026 at 09:35, 1 hour 8 minutes ago stc group unveils its vision for AI-native networks at Network X 2026
Published on 10/19/2026 at 08:15, 2 hours 28 minutes ago Carrefour strengthens its leadership in convenience retail in France with the acquisition of Codifrance
Published on 10/16/2026 at 18:48, 2 days 15 hours ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/15/2026 at 18:50, 3 days 15 hours ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026